
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions β written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Alopecia risk factors
Introduction
Overview
Overview
Age, medications, sex, family history, and illness are all risk factors for alopecia. Androgenetic alopecia is more common in males and prevalence increases with age. People with a family history of hair loss are at a greater predisposition to developing alopecia compared to individuals who do not have a family history. Psychosocial stress, hormonal imbalance, and illness also increase the risk of alopecia.
Risk Factors
Risk Factors
- Some of the specific risk factors for alopecia are as follows:
- Drugs
- Anticoagulants such as heparin, warfarin [1]
- Anticonvulsants such as [[valproic acid [2] and trimethadione. [3]
- Antidepressants such as fluvoxamine and bupropion [4]
- Beta-blockers such as nadolol [5]
- Medical illness
- Poor hygiene which can predispose to tinea capitis [10]
- Physiological and psychological stress which are associated with telogen effluvium [11]
- Mechanical stressors such as tight braids which is associated with traction alopecia [12]
- Chemicals and hair care products [13]
- Male sex which is at increased risk of androgenetic alopecia [14]
- Age of an individual is also a risk factor. For example, tinea capitis is more common in pediatric populations while the prevalence of androgenetic alopecia increases with age [15]
- Family history of alopecia increases an individual’s predisposition to developing alopecia. [16]
- Drugs
References
References
- β Watras MM, Patel JP, Arya R (2016). “Traditional Anticoagulants and Hair Loss: A Role for Direct Oral Anticoagulants? A Review of the Literature”. Drugs Real World Outcomes. 3 (1): 1β6. doi:10.1007/s40801-015-0056-z. PMCΒ 4819463. PMIDΒ 27747798.
- β Thomson SR, Mamulpet V, Adiga S (2017). “Sodium Valproate Induced Alopecia: A Case Series”. J Clin Dia]]gn Res. 11 (9): FR01βFR02. doi:10.7860/JCDR/2017/28564.10658. PMCΒ 5713753. PMIDΒ 29207731.
- β HOLOWACH J, SANDEN HV (1960). “Alopecia as a side effect of treatment of epilepsy with trimethadione. Report of two cases”. N Engl J Med. 263: 1187. doi:10.1056/NEJM196012082632308. PMIDΒ 13715510.
- β Etminan M, Sodhi M, Procyshyn RM, Guo M, Carleton BC (2018). “Risk of hair loss with different antidepressants: a comparative retrospective cohort study”. Int Clin Psychopharmacol. 33 (1): 44β48. doi:10.1097/YIC.0000000000000191. PMIDΒ 28763345.
- β Shelley ED, Shelley WB (1985). “Alopecia and drug eruption of the scalp associated with a new beta-blocker, nadolol”. Cutis. 35 (2): 148β9. PMIDΒ 3979099.
- β Forouzan P, Cohen PR (2020). “Systemic Lupus Erythematosus Presenting as Alopecia Areata”. Cureus. 12 (6): e8724. doi:10.7759/cureus.8724. PMCΒ 7372242 Check
|pmc=value (help). PMIDΒ 32699719 Check|pmid=value (help). - β Callen JP (2000). “Dermatomyositis”. Lancet. 355 (9197): 53β7. doi:10.1016/S0140-6736(99)05157-0. PMIDΒ 10615903.
- β Vincent M, Yogiraj K (2013). “A Descriptive Study of Alopecia Patterns and their Relation to Thyroid Dysfunction”. Int J Trichology. 5 (1): 57β60. doi:10.4103/0974-7753.114701. PMCΒ 3746235. PMIDΒ 23960405.
- β Guo EL, Katta R (2017). “Diet and hair loss: effects of nutrient deficiency and supplement use”. Dermatol Pract Concept. 7 (1): 1β10. doi:10.5826/dpc.0701a01. PMCΒ 5315033. PMIDΒ 28243487.
- β Ayanlowo O, Akinkugbe A, Oladele R, Balogun M (2014). “Prevalence of Tinea Capitis Infection Among Primary School Children in a Rural Setting in South-West Nigeria”. J Public Health Afr. 5 (1): 349. doi:10.4081/jphia.2014.349. PMCΒ 5345463. PMIDΒ 28299118.
- β Asghar F, Shamim N, Farooque U, Sheikh H, Aqeel R (2020). “Telogen Effluvium: A Review of the Literature”. Cureus. 12 (5): e8320. doi:10.7759/cureus.8320. PMCΒ 7320655 Check
|pmc=value (help). PMIDΒ 32607303 Check|pmid=value (help). - β Billero V, Miteva M (2018). “Traction alopecia: the root of the problem”. Clin Cosmet Investig Dermatol. 11: 149β159. doi:10.2147/CCID.S137296. PMCΒ 5896661. PMIDΒ 29670386.
- β Nicholson AG, Harland CC, Bull RH, Mortimer PS, Cook MG (1993). “Chemically induced cosmetic alopecia”. Br J Dermatol. 128 (5): 537β41. doi:10.1111/j.1365-2133.1993.tb00231.x. PMIDΒ 8504045.
- β Kische H, Arnold A, Gross S, Wallaschofski H, VΓΆlzke H, Nauck M; et al. (2017). “Sex Hormones and Hair Loss in Men From the General Population of Northeastern Germany”. JAMA Dermatol. 153 (9): 935β937. doi:10.1001/jamadermatol.2017.0297. PMCΒ 5817427. PMIDΒ 28403384.
- β Mahmoudi H, Salehi M, Moghadas S, Ghandi N, Teimourpour A, Daneshpazhooh M (2018) Dermoscopic Findings in 126 Patients with Alopecia Areata: A Cross-Sectional Study. Int J Trichology 10 (3):118-123. DOI:10.4103/ijt.ijt_102_17 PMID: 30034191
- β Wang S, Ratnaparkhi R, Piliang M, Bergfeld WF (2018). “Role of family history in patchy alopecia areata”. Dermatol Online J. 24 (10). PMIDΒ 30677822.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ogechukwu Hannah Nnabude, MD
